Cargando…
Population Pharmacokinetic Model of N-acetylmannosamine (ManNAc) and N-acetylneuraminic acid (Neu5Ac) in Subjects with GNE Myopathy
BACKGROUND: GNE myopathy is a rare genetic muscle disease resulting from deficiency in an enzyme critical for the biosynthesis of N-acetylneuraminic acid (Neu5Ac, sialic acid). The uncharged Neu5Ac precursor, N-acetylmannosamine (ManNAc), is under development as an orphan drug for treating GNE myopa...
Autores principales: | Van Wart, Scott, Mager, Donald E., Bednasz, Cindy J., Huizing, Marjan, Carrillo, Nuria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206310/ https://www.ncbi.nlm.nih.gov/pubmed/33893973 http://dx.doi.org/10.1007/s40268-021-00343-6 |
Ejemplares similares
-
Safety and efficacy of N-acetylmannosamine (ManNAc) in patients with GNE myopathy: an open-label phase 2 study
por: Carrillo, Nuria, et al.
Publicado: (2021) -
Glycoengineering Human Neural and Adipose Stem Cells with Novel Thiol-Modified N-Acetylmannosamine (ManNAc) Analogs
por: Du, Jian, et al.
Publicado: (2021) -
Crystal Structure of the N-Acetylmannosamine Kinase Domain of GNE
por: Tong, Yufeng, et al.
Publicado: (2009) -
UDP-N-Acetylglucosamine 2-Epimerase/N-Acetylmannosamine Kinase (GNE) Binds to Alpha-Actinin 1: Novel Pathways in Skeletal Muscle?
por: Amsili, Shira, et al.
Publicado: (2008) -
Identification of an Alu element‐mediated deletion in the promoter region of GNE in siblings with GNE myopathy
por: Garland, Jennifer, et al.
Publicado: (2017)